- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sensorion SA (ALSEN)
The Sensorion SA share price today is 0.4060, view EPA ALSEN stock exchange data. Track the latest Sensorion SA share price with real-time updates on ALSEN stock performance including market cap, day range, 52-week range and dividend yield. Access ALSEN charts, earnings dates and analyst estimates to support your investment decisions.
0.4060
+0.0025(+0.62%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.4035
0.4350
52 wk Range
0.2730
0.8080
ALSEN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.40350.4350
52 wk Range
0.27300.8080
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALSEN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
1.3025
Upside
+220.81%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Sensorion SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Sensorion SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1.3025
(+220.81% Upside)
Earnings
Latest Release
18-03-2026
EPS / Forecast
-0.04 / -0.05
Revenue / Forecast
3.5M / 2.3M
Compare ALSEN to Peers and Sector
Metrics to compare | ALSEN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALSENPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.1x | −2.8x | −0.6x | |
PEG Ratio | 1.01 | −0.04 | 0.00 | |
Price/Book | 4.7x | −0.7x | 2.6x | |
Price / LTM Sales | 36.2x | 14.4x | 3.2x | |
Upside (Analyst Target) | 172.2% | 167.7% | 48.1% | |
Fair Value Upside | Unlock | −1.5% | 5.8% | Unlock |
Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France. The company develops SENS-501, a dual AAV vector gene therapy development product for restoring hearing in patients with mutations in OTOF gene in Phase 1/2 clinical trials; and SENS-601, a candidate for the treatment of hearing loss caused by mutations of the GJB2 gene in preclinical studies. It is also developing SENS-40, a small molecule in Phase 2b clinical trials to treat sudden sensorineural hearing loss; prevention of residual hearing loss following cochlear implantation in Phase 2a clinical trials; and prevention of cisplatin-induced ototoxicity in Phase 2a clinical trials. The company was incorporated in 2009 and is headquartered in Montpellier, France.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Sensorion SA (ALSEN) Share Price Today?
The Sensorion SA share price today is 0.4060.
What is the current Sensorion SA (ALSEN) share price and day range?
As of 08-05-2026, the Sensorion SA share price is 0.4060, with a previous close of 0.4060. The share price has ranged from 0.4035 to 0.4350 today, while the 52-week range spans from 0.2730 to 0.8080.
What Is the Sensorion SA Market Cap?
As of today, Sensorion SA market cap is 208.9800M.
What Is the Sensorion SA (ALSEN) Share Price Target?
The average 12-month share price target for Sensorion SA is 1.3025, with a high estimate of 2 and a low estimate of 1. 4 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +220.81% Upside potential.
What Is Sensorion SA's Earnings Per Share (TTM)?
The Sensorion SA EPS (TTM) is -0.0980.
When Is the Next Sensorion SA Earnings Date?
Sensorion SA will release its next earnings report on 03-06-2026.
From a Technical Analysis Perspective, Is ALSEN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Sensorion SA Trade On?
Sensorion SA is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Sensorion SA?
The stock symbol for Sensorion SA is "ALSEN."
How Many Times Has Sensorion SA Stock Split?
Sensorion SA has split 0 times.
How Many Employees Does Sensorion SA Have?
Sensorion SA has 63 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.